Agenda
Saturday, October 13, 2018
7:00 am |
Registration |
7:30 am – 8:20 am |
Continental Breakfast/Poster Viewing/Exhibitors
|
8:20 am – 8:40 am |
Welcome
Susan Smyth, MD |
8:40 am – 9:15 am |
Presidential Speaker: Common Mistakes in Adult Congenital Heart Disease: What the Practitioner Should Know
Carole A. Warnes, MD Mayo Clinic
Dr. Warnes is a Professor of Medicine and a consultant in the Department of Cardiovascular Diseases and Pediatric Cardiology at Mayo Clinic in Rochester, Minnesota.
She received her medical degree from Newcastle upon Tyne University in England and then after general medical training pursued cardiology training in London at the National Heart Hospital. Here she developed an interest in adult congenital heart disease (ACHD) after working with Jane Somerville. She then took a research position at National Institutes of Health (NIH) in the United States before returning to the National Heart Hospital in London for another two years as a British Heart Foundation Scholar and Senior Registrar working in ACHD.
Mayo Clinic
She joined the Department of Cardiovascular Diseases at Mayo Clinic in 1987, where she began the Adult Congenital Heart Disease Clinic.
Honors & Awards
Cardiovascular Teacher of the Year 8 times
Extramural
Founding member of International Society for Adult Congenital Heart Disease (ISACHD)
Objectives:
- Recognize some common clinical errors in the management of adult congenital heart disease.
- Recognize common echocardiographic mistakes in adults with congenital heart disease.
- Delineate some of the common residua and sequelae encountered in adults with repaired congenital heart disease.
Session Chair: Majd Makoul, MD
|
8:45 am – 9:50 am |
Practice Management:Don’t Have a Heart Attack… What Every Practice Needs to Know about Government Audits and Investigations
Jennifer L. Wintergerst, LLP
This presentation will provide attendees with an overview of the relevant fraud and abuse laws that impact healthcare providers, will discuss recent developments in the area of fraud abuse, including highlights from recent cases involving cardiology, and will provide practical tips for dealing with government investigations or responding to government inquiries.
Session Chair: Pat Horvat, RN
|
9:15 am – 9:50 am |
Distinguished Lecturer: New Devices and Medicines in Heart Failure: How to Improve Care
Randall Starling, MD, MPH
Cleveland Clinic
Heart failure is a growing global epidemic. Millions of people have heart failure globally; there are over 1 million hospitalizations yearly in the USA. Heart failure mortality and morbidity are among the highest of all chronic diseases. The new changes in the heart failure guidelines will be presented. Unfortunately despite the availability of guidelines and evidence based therapies many patients do not receive the proper medications at the ideal doses. Process improvement and techniques to improve utilization of life saving medications will be reviewed. Updates for HF with reduced and preserved ejection fraction and new clinical trials in progress will be reviewed. About 10% of the heart failure population have advanced heart failure or stage D. Stage D patients consume tremendous resources, are frequently hospitalized and have highest mortality.
Impactful new and emerging therapies for stage D heart failure will be presented.
Objectives:
- Learn about the new changes in the heart failure guidelines
- Utilize Process of Care approaches to optimize care of HFrEF and HFpEF patients
- Understand the current therapies for Stage D Heart Failure
Session Chair: Navin Rajagopalan, MD
|
9:50 am -10:10 am |
Refreshment Break, Exhibits, Poster Viewing |
10:10 am – 11:00 am |
Honorable Maestro Speaker
Deepak Bhatt, MD, MPH Bringham and Women's Hospital
Chairs: Susan Smyth, MD and Pat Withrow, MD
|
10:10 am – 11:10 am |
Practice Management
Lindy Lady
Kentucky Medical Association
At the end of this session attendees will be able to:
- Share coverage/policy/legislative updates applicable to CPT
- Connect with KMA for help addressing policy issues and other barriers
- Participate in the KMA Public Health Commission
Chair: Pat Horvat, RN
|
11:00 am – 11:10 am |
Presentation of the 2018 Honorable Maestro Award
Roberto Bolli, MD, FAHA, FACC presented by Juan Villafane, MD, FACC
|
11:10 am – 11:30 am |
FIT Oral Abstract Presentations
A Retrospective Analysis of Dual Anti-Platelet Therapy vs Aspirin Plus Oral Anticoagulation following Transcatheter Aortic Valve Replacement (TAVR)
Nicholas Hornbuckle, PharmD, MBA
Early vs Delayed Catheter-Directed Thrombolytic Therapy in Management of Submassive Pulmonary Embolism
Sara Klinger, DO
Using the 4th Versus 5th Generation Troponin Assay to Predict In-Hospital Mortality
Levi May, MD
Session Chair: Khaled Ziada, MD
|
11:30 am – 12:00 pm |
Box Lunch with Exhibitors |
11:30 am – 12:00 pm |
FIT Lunch
|
12:00 pm |
Afternoon Announcements, Prizes, and National Speaker
Chair: Linda Otavalro Orozco, MD
|
12:00 pm -12:20 pm |
ACC Remarks
Andrew Miller, MD, FACC, Chair, ACC Board of Governors
|
12:20 pm – 12:55 pm |
ACC Speaker
Claire Duvernoy, MD
University of Michigan School of Medicine
Objectives:
- To discuss the ACC’s current and future strategic plan
- Current and future mission and vision
- Transition from the triple to the quadruple aim
- Role of innovation
- To discuss the ACC’s evolving core values
- Patient-centered
- Teamwork and collaboration
- Professionalism and excellence
- To discuss the ACC’s vision for diversity and equity
- Role of the Diversity Taskforce
- Action Items for DE&I for 2019
- Role of the Women in Cardiology Section
|
1:00 pm – 2:20 pm |
Concurrent Session: Echocardiography
Echo Evaluation of Aortic Stenosis
Michelle Bay, RDCS
Objectives:
- Understand the disease process of AS
- Refresh our memories on accurate AS measurements
- Understand how aortic stenosis cases in our labs impact our accreditation.
What to Do with Discrepant Numbers in Aortic Stenosis Quantification
Mikel Smith, MD
Low Flow Low Gradient and Normal Flow Low Gradient Severe AS
Vedant Gupta, MD
- Define Low Flow/Low Gradient and Paradoxical Low Flow/Low Gradient aortic stenosis.
- Identify echocardiographic parameters to make these diagnoses and common sources of error.
- Understand the management of this disease state in the age of transcatheter aortic valve implantation (TAVI) and the role of adjunct imaging.
Post AVR Assessment
Marcus Stoddard, MD
Chairs: Larry Todd Breeding, MD and Sunil Mankad, MD
Moderators: LT Breeding, MD and Sunil Mankad, MD
|
1:00 pm – 2:20 pm |
Concurrent Session: Updates in Advanced Heart Failure (+/- Pulm HTN)
Current Pathology Spectrum of Native End Stage Heart Disease and Post Transplant
William O'Connor, MD
Objectives:
- Successfully compare normal cardiac segmental anatomy with TGA examples to understand the concept of ventriculoarterial discordance.
- Recognize TGA associated atrial septal, ventricular septal , subvalvar and coronary artery anatomy.
- Understand route of post surgical blood flow in specimens with atrial switch/Mustard procedure
Top-Five Basic Tricks When Seeing a Patient with CRT
John Mandrola, MD
Setting Up a Cardio MEMS Program
Peggy Hardesty, MSN, APRN
Objectives:
- Participants will be able to define patients appropriate for Cardiomems implant and monitoring
- Participants will be able to state benefits of remote monitoring
- Participants will be able to state basic requirements for implementing a Caridomems program
Setting Up an ECMO Program at a Community Based Hospital
Julia Jones, MD
This session will review necessary personnel and infrastructure required in order to initiate an extracorporeal membrane oxygenation program. Review will include need for institutional commitment, identification of necessary equipment, documentation and reimbursement, establishment of protocols, staff education, and patient identification and selection.
Chairs: Steven Press, ACNP and Navin Rajagopalan, MD
Moderators: Navin Rajagopalan, MD and Steve Press, ACNP
|
1:00 pm – 2:20 pm |
Concurrent Session: Congenital Heart Disease; Transposition of the Great Arteries;
From Fetus to Adulthood
Echocardiographic Assessment of TGA
Lucinda Wright, MD
3 objectives:
- Review echocardiographic findings in the fetus with TGA
- Review echocardiographic findings in the newborn with TGA.
- Review common echocardiographic findings after arterial switch operation for repair of D-TGA.
Surgical Interventions for TGA Through the History
James Quintessenza, MD
- Be familiar with the current surgical operation for TGA
- Understand factors that affect surgical outcomes for TGA patients
Hands on and Pathology Review of TGA Real Life Specimens
William O’Connor, MD
Objectives:
- Successfully compare normal cardiac segmental anatomy with TGA examples to understand the concept of ventriculoarterial discordance.
- Recognize TGA associated atrial septal, ventricular septal , subvalvar and coronary artery anatomy.
- Understand route of post surgical blood flow in specimens with atrial switch/Mustard procedure
Session Chairs: Majd Makhoul, MD and Douglas Schneider, MD
|
1:00 pm – 2:20 pm |
Concurrent Session: Improving CV Care and Preventing CV Disease (Quality)
Stroke Encounter Quality Improvement Project (SEQIP) After 5 years: How a System of Care Works in Kentucky?
Kerri Remmel, MD, Ph D
Appropriateness of PCI: What Has Changed From 2012 to 2017?
Divyesh Bhatka, MD
Session objectives:
- Origins and rational for AUC in PCI,
- Design and use of AUC criteria,
- Changes in AUC guidelines from 2012 to 2017.
STEMI networks – Process and Impact on Outcomes in Kentucky
Khaled Ziada, MD
Contribution of Women Heart Health Centers to Quality of Care
Gretchen Wells, MD
Chairs: Chris McIntyre, MD and Khaled Ziada, MD
|
2:20 pm – 2:40 pm |
Refreshment Break, Poster Viewing |
2:40 pm – 4:00 pm |
Concurrent Session: Echocardiography
ACI in Valvular Heart Disease (Mitral Regurgitation)
Arash Seratnahaei, MD
Objectives:
- Provide an overview of advanced cardiovascular imaging in the evaluation of mitral regurgitation
- Discuss the importance of identifying the etiology and quantification of mitral regurgitation
- Explain CMR techniques used to assess mitral regurgitation
Mitral Valve Masses
John Kotter, MD
- Discuss mitral valve anatomy
- Differentiate common mitral valve masses
Mitral Regurgitation Quantification
Saretta Craft, RDCS
At the conclusion of this presentation, the audience should be able to:
- Describe the key mechanism of MR
- Identify causes of chronic and acute MR
- Discuss how 2D, Color Flow, and spectral Doppler measurements are used to assess severity of MR.
The Emerging Role of 3D Echo in the Assessment of Mitral Valve Disease
Sunil Mankad, MD
Objectives:
- Describe the emerging role of 3D echocardiography in the evaluation of mitral stenosis and mitral balloon valvuloplasty.
- Utilize the 3D echocardiography to better guide surgical mitral valve repair.
- Apply 3D echocardiographic principles and techniques to better comprehend the complexities of mitral annular dynamics.
Chairs: John Kotter, MD and Brian Lea, MD
Moderators: Brian Lea, MD and John Kotter, MD
|
2:40 pm – 4:00 pm |
Concurrent Session: Updates in Advanced Heart Failure (+/- Pulm HTN)
Pulmonary Hypertension
John McConnell, MD
- Review World Health Organization Classifications for Pulmonary Arterial Hypertension
- Understand the diagnostic workup for patients with suspected Pulmonary Arterial Hypertension
- Discuss the three treatment pathways for Pulmonary Arterial Hypertension
- Treatment options for Pulmonary Arterial Hypertension
- Review Risk Assessment tools for Pulmonary Arterial Hypertension
Approach to Common LVAD Complications
Gregory F. Egnaczyk, MD
Learning Objectives:
- Review the common complications of LVAD therapy
- Learn an approach to an LVAD patient with neurologic symptoms?
- Learn an approach to an LVAD patient with gastrointestinal bleeding?
- Learn an approach to an LVAD patient with shortness of breath?
- Recognize the alarms from an LVAD device that require immediate attention?
Cardio-Oncology
Maya Guglin, MD
Objectives:
- To understand the difference between anthracycline and trastuzumab-induced cardiomyopathy
- To realize the potential of pharmacologic prevention of cardiotoxicity
- To analyze the evidence for and against cardiac monitoring and pharmacologic prevention of cardiotoxicity
Chairs: Navin Rajagopalan, MD and Peggy Hardesty, MSN, APRN
Moderators: Peggy Hardesty, MSN, APRN and Steve Press, ACNP
|
2:40 pm – 4:00 pm |
Concurrent Session: Congenital Heart Disease; Transposition of the Great Arteries;
From Fetus to Adulthood
The Tale of Two Switches
Craig Alexander, MD
Objectives:
- Understand the basic hemodynamic condition of the Mustard or Senning Atrial Switch Operation
- Understand the basic hemodynamic condition of the Jatene Arterial Switch Operation
- Review the Most Common Issues associated with both atrial switch and arterial switch operations
Advanced Cardiac Imaging in TGA
Preeti Ramachandran, MD
Interventional Catheterization in TGA
Andrew Leventhal, MD & Ryan Leahy, MD
This lecture will focus on indications for cardiac catheterization in patients with TGA and special techniques and equipment for successful diagnostic and interventional catheterization.
Common Arrhythmias in Palliated TGA; Diagnosis and Management
Kelvin Lau, MD and Shaun Mohan, MD
Objectives are:
- Understanding and recognizing the common arrhythmias in palliated TGA.
- Knowing the post-surgical anatomy and relevance to planning an ablation in palliated TGA.
- Knowing the importance of lifelong surveillance for arrhythmias
Session Chairs: Brian Holland, MD and Juan Villafane, MD, FACC
|
2:40 pm – 4:00 pm |
Concurrent Session: Improving CV Care and Preventing CV Disease (Prevention)
Cardiac Rehabilitation – Value and Place in the Continuum of Care
Jacob Stone
Lipid Lowering Therapy Beyond Statins - What We Need to Know
Mary B Covell, PharmD, MPH, BCPS
What Cardiologists Need to Know About New Anti-Diabetic Therapies J. Scott Hayes, Pharm.D., BCPS
Objectives:
- Summarize the new ADA treatment guidelines
- Determine which diabetes medications are most appropriate for use in relation to cardiovascular risks in a patient
- Identify potential risk associated with diabetes medications or classes of medications.
Effect of New Hypertension Guidelines on Cardiology Practices
Stacy Taylor, Pharm.D., MHA, BCPS
Objectives:
- Describe the epidemiologic impacts of the 2017 ACC/AHA Hypertension Guidelines on hypertension diagnoses in the United States.
- Compare and contrast the 2017 ACC/AHA Hypertension guidelines with previous hypertension guidelines.
- Describe basic approaches to pharmacologic management of HTN in the general adult population, blacks and non-blacks, and in patients with chronic kidney disease.
Chairs: Christopher Betz, PharmD and Khaled Ziada, MD
|
4:00 pm - 4:10 pm |
19 ACC Award Winners/ Prize Giveaways |
4:10 pm - 5:00 pm |
FIT Jeopardy
Sunil Mankad, MD
|
Honorable Maestro

University of Louisville cardiologist and researcher,
Roberto Bolli, M.D., is director of U of L’s Institute of Molecular Cardiology and serves as scientific director of the Cardiovascular Innovation Institute at the university. He is also a professor and chief of the Division of Cardiovascular Medicine at the School of Medicine. In the past year, he received one of the largest grants ever for medical research at the University of Louisville, to study a promising new type of adult cardiac stem cell that has the potential to treat heart failure. He also led the Stem Cell Summit at the annual meeting of the American Heart Association in Anaheim, California.
Dr. Bolli’s research focus has been on how to repair the heart and cure heart failure using a patient’s own stem cells. It is an approach that could revolutionize the treatment of heart disease.
Continuing Education
The Southern Kentucky Area Health Education Center is accredited by the Kentucky Medical Association (KMA) to provide continuing medical education for physicians.
The Southern Kentucky AHEC designates this live activity for a maximum of (eight and one-half (8.5) credits) AMA PRA Category 1 Credit(s).™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
All persons participating in continuing medical education programs sponsored by the Southern AHEC are expected to disclose any real or perceived
Conflict of interest related to the content of their presentations. The Southern Kentucky AHEC office of Continuing Medical Education presents this activity for educational purposes only. Participants are expected to use their own expertise and judgment while engaged in the practice of medicine. The content of the presentation is provided solely by presenters who have been selected for presentations because of recognized expertise in the field.
KBN Approval: Rockcastle Regional Hospital, Inc. has been approved as a provider of continuing education by the Kentucky Board of Nursing (KBN). Provider #4-0059. Expiration Date December 31, 2018. Kentucky Board of Nursing approval of an individual nursing education program does not constitute endorsement of program content.
Receiving Credit: In order to receive contact hours, you need to attend the offered sessions and complete the evaluation. Participants should only claim those hours of credit actually spent in the educational activity.
OFFERING ANNOUNCEMENT
Participants shall be provided with essential information prior to registration in the form of an offering announcement. The following information must be included:
- Learner outcomes
- Content overview
- Date, time, and presentation schedule
- Presenter
- Number of contact hours
- Fee and refund policy
- Target audience and any prerequisites
Conflict of Interest Disclosure Statements
The following speakers have disclosures:
Divyesh Bhatka, MD
Honorarium/Speakers Bureau – Amgen
Deepak Bhatt, MD, MPH
Research Funding – Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesl, Elsai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, Synaptic, The Medicines Company
Gregory Egnaczyk, MD
Speakers Bureau– Abbott
Peggy Hardesty, MSN, APRN
Speaker/Consulting Teaching – Abbott
J. Scott Hayes, PharmD, BCPS
Stock Options/Employment – Humana
John McConnell, MD
Speakers Bureau/Advisory Board/Consulting – Actelion, Bayer; Speakers Bureau – Genentech; Consulting – Reata; Advisory Board/Consulting – United Therapeutics
Randall Starling, MD, MPH
Research– Novartis & Abbott (Research Grant)
None of the other planners, speakers, authors, reviewers, and staff members had anything to disclose.
Faculty Disclosure Statement:
All planners, speakers, authors, reviewers, and staff members involved with content development for continuing education activities sponsored by the Southern Kentucky Area Health Education Center (AHEC) are expected to disclose any real or perceived conflict of interest related to the content of the activity.
Detailed disclosures will be included in participant materials or given prior to the start of the activity.
Disclaimer
Southern Kentucky Area Health Education Center (AHEC) presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentation is provided solely by presenter(s) who have been selected for presentations because of recognized expertise in their field.